✦ LIBER ✦

I.1 How to conduct clinical trials in elderly cancer patients: clinical issues

✍ Scribed by Droz, J.-P.; Terret, C.

Book ID: 123366781
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 77 KB
Volume: 60
Category: Article
ISSN: 1040-8428
DOI: 10.1016/S1040-8428(13)70008-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

VII.1 How to conduct clinical trials for

VII.1 How to conduct clinical trials for elderly patients with cancer (US perspective)

✍ Extermann, M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

VII.3 How to conduct clinical trials for

VII.3 How to conduct clinical trials for elderly patients with cancer: European/EORTC perspective

✍ Wedding, U. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

I.2 Statistical issues for cancer clinic

I.2 Statistical issues for cancer clinical trials in the elderly

✍ Buyse, M. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Statistical issues for cancer clinical t

Statistical issues for cancer clinical trials in the elderly

✍ M. Buyse 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Recruitment and Retention of Elderly Pat

Recruitment and Retention of Elderly Patients in Clinical Trials: Issues and Strategies

✍ Cassidy, Erin L.; Baird, E.; Sheikh, Javaid I. 📂 Article 📅 2001 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 71 KB

The conduct of phase I-II clinical trial

The conduct of phase I-II clinical trials in children with cancer

✍ Pratt, Charles B. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 677 KB

Phase I Clinical Trials in children with cancer are carried out with therapeutic intent, so as to define antileukemic/antitumor activity, dose-limiting toxicity, maximum tolerated dosage, and pharmacokinetics. These studies define a dosage of an agent or combination that may be used in a larger stud